Colin Love

Colin Love

Direttore/Membro del Consiglio presso
Replimune Ltd.
67 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Colin A. Love was the founder of Replimune Group, Inc. (founded in 2015) where he held the title of Chief Operating Officer from 2015 to 2024.
He is currently working as a Non-Executive Director at Freeline Therapeutics Ltd., as a Director at Replimune Ltd., and as a Director at Replimune (Ireland) Ltd. Dr. Love has previously worked as a Director-Manufacturing Development at Celltech Group Plc, as an Independent Non-Executive Director at Freeline Therapeutics Holdings Plc from 2021 to 2024, as a Vice President-Clinical Operations at Amgen, Inc. from 2011 to 2014, as a Senior Vice President-Product Development at BioVex, Inc. from 2000 to 2011, as a Senior Vice President-Product Development at BioVex Group, Inc. from 2000 to 2013, and as a Senior Vice President-Product Development at BioVex Ltd. Dr. Love has an undergraduate and doctorate degree from the University of Glasgow.

Posizioni attive di Colin Love

SocietàPosizioneInizio
Direttore/Membro del Consiglio 10/07/2017
Direttore/Membro del Consiglio 01/10/2019
Direttore/Membro del Consiglio -

Precedenti posizioni note di Colin Love

SocietàPosizioneFine
REPLIMUNE GROUP, INC. Fondatore 31/05/2024
Corporate Officer/Principal 31/07/2015
AMGEN INC. Direttore Tecnico/Scientifico/R&S 01/01/2014
Corporate Officer/Principal 24/01/2013
Corporate Officer/Principal 01/01/2011
Vedi nel dettaglio l'esperienza di Colin Love

Formazione di Colin Love

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

48

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

  1. Mercati
  2. Insiders
  3. Colin Love
40% di sconto: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA